Clover Health Investments Corp
NASDAQ:CLOV
Clover Health Investments Corp
NASDAQ:CLOV
Price:
0.9272 USD
3.54%
Market Closed
Updated:
May 22, 2024
P/OCF
Price to OCF
Price to OCF
-2.7
Current
-5.4
Median
16
Industry
Higher
than median
Lower
than industry value
Price to Operating Cash Flow (P/OCF) ratio is a valuation multiple that measures the value of a company’s market capitalization relative to the operating cash flow it generates. Some analysts prefer P/OCF over P/E since earnings can be more easily manipulated than cash flows.
P/OCF
=-2.7
Market Cap
/
448.9m
Operating Cash Flow
-168.9m
All Countries
| Market Cap | P/OCF | ||||
|---|---|---|---|---|---|
| US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
448.9m USD | -2.7 | |
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
482.7B USD | 34.8 | |
| US |
|
Elevance Health Inc
NYSE:ELV
|
126.9B USD | 35.5 | |
| US |
|
Anthem Inc
NYSE:ANTM
|
116.4B USD | 13.9 | |
| US |
|
Humana Inc
NYSE:HUM
|
42.8B USD | -18.8 | |
| US |
|
Centene Corp
NYSE:CNC
|
42.1B USD | 12.8 | |
| US |
|
Molina Healthcare Inc
NYSE:MOH
|
20.2B USD | 21 | |
| US |
|
Healthequity Inc
NASDAQ:HQY
|
6.8B USD | 28.1 | |
| BR |
|
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
|
33.6B BRL | 13 | |
| BR |
|
Notre Dame Intermedica Participacoes SA
OTC:NTEDY
|
6.4B USD | 36.2 | |
| US |
|
Progyny Inc
NASDAQ:PGNY
|
2.6B USD | 13.6 |
P/OCF Forward Multiples
Forward P/OCF multiple is a version of the P/OCF ratio that uses forecasted operating cash flow for the P/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/OCF
N/A
2-Years Forward
P/OCF
N/A
3-Years Forward
P/OCF
N/A
You don't have any saved screeners yet
